¹ú²úÂÒÂ×

Digital lab transition: the opportunity for life science R&D labs

T
The Link
By: Saskia Hoving, Mon Sep 16 2024
Saskia Hoving

Author: Saskia Hoving

The life science industry faces mounting challenges: increasing data complexity, rising drug development costs, and the need for greater efficiency. Digital transformation tools offer significant financial and timesaving benefits but implementing them effectively remains a challenge for many organizations. This blog explores the challenges of increased costs and growing data volume facing R&D teams, then delves into the benefits of digital transformation and the journey that labs are on to achieve the full potential it promises.

Rising costs and data challenges

Biotech firms are grappling with an exponential growth in data volume, driven by advances in techniques like multi-omics analysis. reveals that nine out of ten organizations struggle with data volume and heterogeneous data formats. This challenge has substantial financial implications, with the that non-FAIR (Findable, Accessible, Interoperable, and Reusable) data costs the European economy up to €26 billion annually.

Simultaneously, costs in the biopharma sector continue to climb. By 2013, the average cost of bringing a new drug to market had reached $2.8 billion (). With R&D returns in this sector plummeting to just 1.2% (), it's clear that companies must prioritize lab efficiency to remain competitive.

Digital lab benefits

For over two decades, labs have been undergoing digital transformation. This journey began with Laboratory Information Management Systems (LIMS) and has evolved to include advanced analysis tools, automation, cloud computing, bioinformatics, and virtual and augmented reality (VR and AR). Recent advancements in AI and machine learning have accelerated data analysis capabilities.

Emerging technologies such as blockchain for secure data transactions, digital twins for replicating experiments in virtual environments, and the Internet of Things (IoT) for real-time data collection can offer additional opportunities to enhance lab efficiency and data integrity.

According to , full implementation of these innovations across the life science value chain could generate an annual global impact of $130-190 billion.

Digital lab transition not only offers cost reduction, but it can also drive improved data integrity and increased reproducibility. Laboratory robotics can automate repetitive tasks, reducing monotony and allowing researchers to focus on more complex activities.

The journey to digital transformation in research

Despite the clear advantages, transition strategies for digital laboratories remain challenging. Capgemini reports that only 11% of R&D labs have partially scaled up their digital transformation, and just 2% have achieved full implementation.

notes that life science firms are prioritizing AI and cloud investments. AI has enormous potential for processing large datasets. Training large language models and combining datasets can help identify which drugs to develop or repurpose. However, found that although 98% of life sciences companies have invested in AI, none have yet realized its full potential.

McKinsey's findings suggest that broadening investment in technologies beyond analytics tools will unlock the most innovation and value. A recent underscores the urgency of this transition, with 69% of R&D organizations believing that failing to connect and automate their labs will result in a loss of competitive advantage.

Realizing the promise of digital labs

The digital transformation of life sciences R&D is progressing, but significant opportunities remain. Full integration of AI, laboratory robotics, clinical lab automation, cloud computing, and other digital tools is crucial for life science laboratories to stay competitive and drive innovation. As the industry continues to evolve, those who successfully navigate the digital transition will be best positioned to lead in research, drug development, and ultimately, patient care.

For a greater understanding of the full transformation journey for life sciences R&D, read . This report covers in detail the challenges addressed above and describes the stages labs must progress through to achieve full digital transformation. It explores innovative solutions that R&D organisations are embracing today and examples of the impact that this transformation brings.

Related content

Don't miss the latest news & blogs, subscribe to The Link Alerts!


Saskia Hoving

Author: Saskia Hoving

In the Dordrecht office, Marketing Manager Saskia Hoving is chief editor of The Link Newsletter and The Link Blog, covering trends & insights for all facilitators of research. Focusing on the evolving role of libraries regarding SDGs, Open Science, and researcher support, she explores academia's intersection with societal progress. With a lifelong passion for sports and recent exploration into "Women's inclusion in today's science", Saskia brings dynamic insights to her work.